NYSE:XTNT

Xtant Medical Holdings Stock Insider Trading

Healthcare > Medical - Devices

Buy XTNT

*Your capital is at risk

$0.460

-0.0049 (-1.05%)

At Close: Jun 03, 2026

Xtant Medical Holdings Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -91.69. In total, the insiders bought 13.66M and sold 35.35M XTNT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-91.69
● Buy	13.66M shares
● Sell	35.35M shares
72% Buy Activity Weak Negative Correlation
Sell Signal Medium Confidence Jun 01, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -91.69. Confidence increased due to high data reliability score of 90.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 15, 2026 Sell	Common Stock F-InKind	Schallenberger Mark A. Chief Operating Officer	C-Suite Officer	7 709 Value: $4K
Jan 15, 2026 Sell	Common Stock F-InKind	Neils Scott C CFO And Assistant Secretary	C-Suite Officer	8 084 Value: $5K
Nov 15, 2025 Buy	Performance Stock Units (PSUs) A-Award	Neils Scott C CFO And Assistant Secretary	C-Suite Officer	526 582 Value: $242.3K
Nov 15, 2025 Buy	Common Stock A-Award	Neils Scott C CFO And Assistant Secretary	C-Suite Officer	263 291 Value: $121.1K
Nov 15, 2025 Buy	Performance Stock Units (PSUs) A-Award	Schallenberger Mark A. Chief Operating Officer	C-Suite Officer	584 506 Value: $268.9K
Nov 15, 2025 Buy	Performance Stock Units (PSUs) A-Award	Browne Sean E President And CEO	CEO / President	789 874 Value: $363.4K
Nov 15, 2025 Buy	Common Stock A-Award	Lipschultz Tyler Director	Director	158 228 Value: $72.8K
Nov 15, 2025 Buy	Common Stock A-Award	Bakewell John K Director	Director	158 228 Value: $72.8K
Nov 15, 2025 Buy	Common Stock A-Award	Bakewell John K Director	Director	158 228 Value: $72.8K
Nov 15, 2025 Buy	Common Stock A-Award	Vizirgianakis Stavros G. Director	Director	553 797 Value: $254.8K
Nov 15, 2025 Buy	Common Stock A-Award	Beeson Jonn R. Director	Director	158 228 Value: $72.8K
Nov 15, 2025 Buy	Common Stock A-Award	Jain Abhinav Director	Director	158 228 Value: $72.8K
Nov 15, 2025 Buy	Common Stock A-Award	Browne Sean E President And CEO	CEO / President	394 937 Value: $181.7K
Nov 15, 2025 Buy	Common Stock A-Award	Schallenberger Mark A. Chief Operating Officer	C-Suite Officer	292 253 Value: $134.5K
Aug 15, 2025 Sell	Common Stock F-InKind	Browne Sean E President And CEO	CEO / President	10 605 Value: $7K
Aug 15, 2025 Sell	Common Stock F-InKind	Neils Scott C CFO	C-Suite Officer	34 131 Value: $21.5K
Aug 15, 2025 Sell	Common Stock F-InKind	Neils Scott C CFO	C-Suite Officer	34 131 Value: $21.5K
Aug 15, 2025 Sell	Common Stock F-InKind	Browne Sean E President And CEO	CEO / President	10 605 Value: $7K
Aug 01, 2025 Buy	Common Stock J-Other	Lipschultz Tyler	Director	0 Value: $0
Aug 01, 2025 Buy	Common Stock J-Other	Jain Abhinav	Director	0 Value: $0
Aug 01, 2025 Buy	Common Stock J-Other	Jain Abhinav	Director	0 Value: $0
Aug 01, 2025 Buy	Common Stock J-Other	Lipschultz Tyler	Director	0 Value: $0
Apr 10, 2025 Buy	Common Stock	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	0 Value: $0
Apr 10, 2025 Buy	Common Stock	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	0 Value: $0
Apr 10, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	17 109 618 Value: $7.19M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT XTANT MEDICAL HOLDINGS INC

Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect ...

Read Full Profile Here